REVVITY, INC.

RVTY

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Deerfield Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Deerfield ManagementNEWFeb 17, 2026

Shares: 10,323Value: $999K

**Signal Note: Deerfield Initiates RVTY Position** Deerfield's $999K entry into Revvity signals conviction in the life sciences tools/diagnostics platform as it expands beyond legacy PerkinElmer instrumentation. The timing aligns with Revvity's portfolio optimization post-spin, though the modest position size suggests either opportunistic entry or a broader healthcare infrastructure thesis rather than a binary catalyst bet. Monitor upcoming earnings/guidance for operational leverage in high-margin diagnostics and lab automation segments.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

RDNT1 fund VTR1 fund PHVS1 fund PMVP1 fund ALHC1 fund ATRC1 fund BCRX1 fund NBIX

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: